Bristol-Myers Squibb Reports Third Quarter Financial Results

Go back to Bristol-Myers Squibb Reports Third Quarter Financial Results

Bristol-Myers Squibb (BMY) Tops Q3 EPS by 20c; Raises Outlook

October 25, 2018 7:00 AM EDT

Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.09, $0.20 better than the analyst estimate of $0.89. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.64 billion.

We had a very good quarter with strong commercial performance and advances in our portfolio through important... More